Ökonomische Bewertung der Grippeschutzimpfung am Arbeitsplatz in Deutschland – Eine Analyse der Grippesaison 2024/2025 aus betrieblicher Perspektive

Economic evaluation of influenza vaccination at the workplace in Germany – An analysis of the 2024/2025 influenza season from a business perspective Objective: This study aims to analyse the cost-effectiveness of workplace influenza vaccination in Germany during the 2024/2025 influenza season. A focus is placed on the corporate perspective to determine the financial effects of such programmes. Methods: An updated decision analysis model was developed on the basis of national data sources and previously published literature. Extensive scenario analyses were conducted to assess the financial impact and costeffectiveness of vaccination programmes across companies of different sizes and industries. Additionally, a nationwide scenario including all employees was examined. Results: In the base case (n = 500 employees, vaccination rate 20 %), the vaccination programme prevented 5.9 flu cases per year and, consequently, the loss of 29.4 productive days, leading to savings of € 11,162. With programme costs of € 2,564, this results in net savings of € 8,958 and a return on investment (ROI) of 335 %, i. e. savings of € 4.35 per euro invested. Scenario analyses of different industries and company sizes refine this outcome but confirm the same trend. Conclusions: The results of both the base case and the scenario analyses demonstrate that workplace influenza vaccination can lead to substantial cost savings for companies and generate a significant ROI. The financial benefits of the vaccination programme increase with higher vaccination rates, larger workforces and rising labour costs. These findings highlight the economic attractiveness of workplace influenza vaccination programmes and confirm that such initiatives not only improve employee health but also enhance productivity and reduce costs for companies. Therefore, businesses should maintain and expand their vaccination programmes in order to reap both health and productivity benefits. Keywords: influenza vaccination – cost-effectiveness – workplace – productivity – vaccination rate